SyntheX

Developer of a proprietary drug discovery platform designed for finding protein interaction disruptors, bridgers, and molecular glue degraders. The company's platform utilizes genetically engineered circuits, technologies, and proprietary DNA (deoxyribonucleic acid)-encoded peptide and macrocycle libraries that rely on intracellular drug selection as opposed to in vitro screening, enabling healthcare institutions to serve human health for the treatment of cancer and rare diseases.

8VC

🏥 Healthcare